|
1
|
Siegel RL, Miller KD and Jemal A: Cancer statistics. CA Cancer J Clin. 70:7–30. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, Stein KD, Alteri R and Jemal A: Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 66:271–289. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Roche J: The epithelial-to-mesenchymal transition in cancer. Cancers (Basel). 10:522018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pastushenko I and Blanpain C: EMT transition states during tumor progression and metastasis. Trends Cell Biol. 29:212–226. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yeung KT and Yang J: Epithelial-mesenchymal transition in tumor metastasis. Mol Oncol. 11:28–39. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xu Y, Liu J, Chen WJ, Ye QQ, Chen WT, Li CL and Wu HT: Regulation of N6-methyladenosine in the differentiation of cancer stem cells and their fate. Front Cell Dev Biol. 8:5617032020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu S, Zhuo L, Wang J, Zhang Q, Li Q, Li G, Yan L, Jin T, Pan T, Sui X, et al: METTL3 plays multiple functions in biological processes. Am J Cancer Res. 10:1631–1646. 2020.PubMed/NCBI
|
|
8
|
Deng X, Su R, Weng H, Huang H, Li Z and Chen J: RNA N(6)-methyladenosine modification in cancers: current status and perspectives. Cell Res. 28:507–517. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tian R, Zhang S, Sun D, Bei C, Li D, Zheng C, Song X, Chen M, Tan S, Zhu X, et al: M6A Demethylase FTO plays a tumor suppressor role in thyroid cancer. DNA Cell Biol. 39:2184–2193. 2020. View Article : Google Scholar
|
|
10
|
Guo T, Liu DF, Peng SH and Xu AM: ALKBH5 promotes colon cancer progression by decreasing methylation of the lncRNA NEAT1. Am J Transl Res. 12:4542–4549. 2020.PubMed/NCBI
|
|
11
|
Lasman L, Krupalnik V, Viukov S, Mor N, Aguilera-Castrejon A, Schneir D, Bayerl J, Mizrahi O, Peles S, Tawil S, et al: Context-dependent functional compensation between Ythdf m(6)A reader proteins. Genes Dev. 34:1373–1391. 2020.PubMed/NCBI
|
|
12
|
Zhang L, Wan Y, Zhang Z, Jiang Y, Lang J, Cheng W and Zhu L: FTO demethylates m6A modifications in HOXB13 mRNA and promotes endometrial cancer metastasis by activating the WNT signaling pathway. RNA Biol. 18:1265–1278. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ma XX, Cao ZG and Zhao SL: m6A methyltransferase METTL3 promotes the progression of prostate cancer via m6A-modified LEF1. Eur Rev Med Pharmacol Sci. 24:3565–3571. 2020.PubMed/NCBI
|
|
14
|
Yang Z and Jiang X, Li D and Jiang X: HBXIP promotes gastric cancer via METTL3-mediated MYC mRNA m6A modification. Aging (Albany NY). 12:24967–24982. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Qu N, Qin S, Zhang X, Bo X, Liu Z, Tan C, Wen G and Jiang H: Multiple m6A RNA methylation modulators promote the malignant progression of hepatocellular carcinoma and affect its clinical prognosis. BMC Cancer. 20:1652020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang Y, Kang M, Zhang B, Meng F, Song J, Kaneko H, Shimamoto F and Tang B: m6A modification-mediated CBX8 induction regulates stemness and chemosensitivity of colon cancer via upregulation of LGR5. Mol Cancer. 18:1852019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li J, Han Y, Zhang H, Qian Z, Jia W, Gao Y, Zheng H and Li B: The m6A demethylase FTO promotes the growth of lung cancer cells by regulating the m6A level of USP7 mRNA. Biochem Biophys Res Commun. 512:479–485. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang Y, Liu S, Zhao T and Dang C: METTL3 mediated m6A modification of Bcl-2 mRNA promotes non small cell lung cancer progression. Oncol Rep. 46:1632021. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhu Z, Qian Q, Zhao X, Ma L and Chen P: N6-methyladenosine ALKBH5 promotes non-small cell lung cancer progress by regulating TIMP3 stability. Gene. 731:1443482020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou J, Xiao D, Qiu T, Li J and Liu Z: Loading MicroRNA-376c in extracellular vesicles inhibits properties of non-small cell lung cancer cells by targeting YTHDF1. Technol Cancer Res Treat. Dec 7–2020.(Epub ahead of print). doi: 10.1177/1533033820977525. View Article : Google Scholar
|
|
21
|
Wang M, Liu J, Zhao Y, He R, Xu X, Guo X, Li X, Xu S, Miao J, Guo J, et al: Upregulation of METTL14 mediates the elevation of PERP mRNA N6 adenosine methylation promoting the growth and metastasis of pancreatic cancer. Mol Cancer. 19:1302020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yi D, Wang R, Shi X, Xu L, Yilihamu Y and Sang J: METTL14 promotes the migration and invasion of breast cancer cells by modulating N6 methyladenosine and hsa miR 146a 5p expression. Oncol Rep. 43:1375–1386. 2020.PubMed/NCBI
|
|
23
|
Okayama H, Kohno T, Ishii Y, Shimada Y, Shiraishi K, Iwakawa R, Furuta K, Tsuta K, Shibata T, Yamamoto S, et al: Identification of genes upregulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinomas. Cancer Res. 72:100–111. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ahmadiankia N and Khosravi A: Significance of epithelial-to-mesenchymal transition inducing transcription factors in predicting distance metastasis and survival in patients with colorectal cancer: A systematic review and meta-analysis. J Res Med Sci. 25:602020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zheng L, Li N, Guo F, Jian XC, Jiang CH, Yin P, Min AJ and Huang L: Twist-related protein 1 enhances oral tongue squamous cell carcinoma cell invasion through β-catenin signaling. Mol Med Rep. 11:2255–2261. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ni L, Li Z, Shi X, Yao C, Sun J, Ai M, Li S, Liu Y, Xu F, Zhou Y, et al: Rosthorin A inhibits non-small cell lung cancer cell growth and metastasis through repressing epithelial-mesenchymal transition via downregulating Slug. Anticancer Drugs. 31:997–1003. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang J, Guo S, Piao HY, Wang Y, Wu Y, Meng XY, Yang D, Zheng ZC and Zhao Y: ALKBH5 promotes invasion and metastasis of gastric cancer by decreasing methylation of the lncRNA NEAT1. J Physiol Biochem. 75:379–389. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang X, Feng J, Xue Y, Guan Z, Zhang D, Liu Z, Gong Z, Wang Q, Huang J, Tang C, et al: Structural basis of N(6)-adenosine methylation by the METTL3-METTL14 complex. Nature. 534:575–578. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lang F, Singh RK and Pei Y: EBV epitranscriptome reprogramming by METTL14 is critical for viral-associated tumorigenesis. PLoS Pathog. 15:e10077962019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Weng H, Huang H, Wu H, Qin X, Zhao BS, Dong L, Shi H, Skibbe J, Shen C, Hu C, et al: METTL14 inhibits hematopoietic stem/progenitor differentiation and promotes leukemogenesis via mRNA m6A modification. Cell Stem Cell. 22:191–205.e9. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sun T, Wu Z, Wang X, Wang Y, Hu X, Qin W, Lu S, Xu D, Wu Y, Chen Q, et al: LNC942 promoting METTL14-mediated m(6)A methylation in breast cancer cell proliferation and progression. Oncogene. 39:5358–5372. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li F, Wang H, Huang H, Zhang L, Wang D and Wan Y: m6A RNA Methylation regulators participate in the malignant progression and have clinical prognostic value in lung adenocarcinoma. Front Genet. 11:9942020. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu J, Ren D, Du Z, Wang H, Zhang H and Jin Y: m6A demethylase FTO facilitates tumor progression in lung squamous cell carcinoma by regulating MZF1 expression. Biochem Biophys Res Commun. 502:456–464. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu X, Xiao M, Zhang L, Li L, Zhu G, Shen E, Lv M, Lu X and Sun Z: The m6A methyltransferase METTL14 inhibits the proliferation, migration, and invasion of gastric cancer by regulating the PI3K/AKT/mTOR signaling pathway. J Clin Lab Anal. 35:e236552021.PubMed/NCBI
|
|
35
|
Ma JZ, Yang F, Zhou CC, Liu F, Yuan JH, Wang F, Wang TT, Xu QG, Zhou WP and Sun SH: METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N6 -methyladenosine-dependent primary MicroRNA processing. Hepatology. 65:529–543. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yang X, Zhang S, He C, Xue P, Zhang L, He Z, Zang L, Feng B, Sun J, Zheng M, et al: METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST. Mol Cancer. 19:462020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen M, Wei L, Law CT, Tsang FH, Shen J, Cheng CL, Tsang LH, Ho DW, Chiu DK, Lee JM, et al: RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2. Hepatology. 67:2254–2270. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chen Y and Yang S: PRDX2 promotes the proliferation and metastasis of non-small cell lung cancer in vitro and in vivo. Biomed Res Int. Aug 27–2020.(Epub ahead of print). doi: 10.1155/2020/8359860.
|
|
39
|
Zhu L, Chen Y, Jing L, Nie K, Xiao Y and Yu H: MicroRNA-629 promotes the tumorigenesis of non-small-cell lung cancer by targeting FOXO1 and activating PI3K/AKT pathway. Cancer Biomark. 29:347–357. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhao Y, Ye X, Chen R, Gao Q, Zhao D, Ling C, Qian Y, Xu C, Tao M and Xie Y: Sirtuin 7 promotes non small cell lung cancer progression by facilitating G1/S phase and epithelial mesenchymal transition and activating AKT and ERK1/2 signaling. Oncol Rep. 44:959–972. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hua W, Zhao Y, Jin X, Yu D, He J, Xie D and Duan P: METTL3 promotes ovarian carcinoma growth and invasion through the regulation of AXL translation and epithelial to mesenchymal transition. Gynecol Oncol. 151:356–365. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chen J, Sun Y, Xu X, Wang D, He J, Zhou H, Lu Y, Zeng J, Du F, Gong A, et al: YTH domain family 2 orchestrates epithelial-mesenchymal transition/proliferation dichotomy in pancreatic cancer cells. Cell Cycle. 16:2259–2271. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Liu W, Zhang B, Xu N, Wang MJ and Liu Q: miR-326 regulates EMT and metastasis of endometrial cancer through targeting TWIST1. Eur Rev Med Pharmacol Sci. 21:3787–3793. 2017.PubMed/NCBI
|
|
44
|
Yu X, Zheng Y, Zhu X, Gao X, Wang C, Sheng Y, Cheng W, Qin L, Ren N, Jia H, et al: Osteopontin promotes hepatocellular carcinoma progression via the PI3K/AKT/Twist signaling pathway. Oncol Lett. 16:5299–5308. 2018.PubMed/NCBI
|
